Comparing 2 hypotheses side-by-side
## Mechanistic Overview Restoration of V-ATPase function reverses lysosomal acidification defect in AD neurons starts from the claim that modulating ATP6V1A, ATP6V0C within the disease context of neuroscience can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview Restoration of V-ATPase function reverses lysosomal acidification defect in AD neurons starts from the claim that modulating ATP6V1A, ATP6V0C within the disease context of neuroscience can redi
## Mechanistic Overview GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance starts from the claim that modulating GRIN2B within the disease context of neuroscience can redirect a disease-relevant process. The original description reads: "**Molecular Mechanism and Rationale** The mechanistic foundation of this hypothesis rests on the intricate relationship between GluN2B-containing NMDA receptors, thalamocortical oscillatory dynamics, and the cellular machinery governing glymphati
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
| Dimension | Restoration of V-ATPase functi | GluN2B-Mediated Thalamocortica |
|---|---|---|
| Mechanistic | 0.680 | 0.750 |
| Evidence | 0.680 | 0.750 |
| Novelty | 0.600 | 0.780 |
| Feasibility | 0.750 | 0.850 |
| Impact | 0.650 | 0.820 |
| Druggability | 0.720 | 0.950 |
| Safety | 0.620 | 0.750 |
| Competition | 0.650 | 0.800 |
| Data | 0.720 | 0.700 |
| Reproducible | 0.700 | 0.750 |
| KG Connect | 0.500 | 0.562 |
No evidence citations yet
No evidence citations yet
4 rounds · quality: 0.76
# Therapeutic Hypotheses: Lysosomal Dysfunction in Alzheimer's Disease ## Hypothesis 1: TFEB Activation to Restore Lysosomal Biogenesis **Title:** TFEB-mediated transcriptional upregulation of lysos...
# Critical Evaluation of Lysosomal Dysfunction Hypotheses in Alzheimer's Disease ## Cross-Hypothesis Methodological Concerns Before addressing individual hypotheses, several systemic weaknesses perv...
# Domain Expert Assessment: Lysosomal Dysfunction Hypotheses in Alzheimer's Disease ## Executive Summary The field of lysosomal dysfunction in Alzheimer's disease has matured considerably, with comp...
{ "ranked_hypotheses": [ { "title": "TFEB-mediated transcriptional upregulation of lysosomal genes as a therapeutic strategy for AD", "description": "Activation of TFEB (master regul...
4 rounds · quality: 0.60
# Theoretical Analysis: GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance ## Key Molecular Mechanisms This hypothesis integrates three interconnected systems: **1. GluN2B-Contai...
## Critical Evaluation: GluN2B-Mediated Thalamocortical Tau Clearance Hypothesis ### Mechanistic Overreach The hypothesis presents an elegant three-step causal chain—GluN2B modulation → thalamocor...
# Expert Assessment: GluN2B-Mediated Thalamocortical Glymphatic Tau Clearance ## Druggability: Moderate-to-Low The hypothesis proposes GRIN2B modulation as a gateway to enhanced tau clearance via ...
{"hypothesis_title": "GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance","synthesis_summary": "The hypothesis presents an innovative three-step mechanistic chain connecting GRIN2B ...
Curated mechanism pathway diagrams from expert analysis
graph TD
A["GluN2B NMDA Receptor
Extrasynaptic Expression"] --> B["Calcium Influx
Ca2+ Permeable Channel"]
B --> C["CaMKII Activation
Calcium-Dependent Kinase"]
C --> D["CREB Phosphorylation
Transcription Factor"]
D --> E["Synaptic Plasticity Genes
LTP Enhancement"]
A --> F["Thalamic Relay Neurons
VB and VPM Nuclei"]
F --> G["Cortical Layer IV
Sensory Input Processing"]
G --> H["Pyramidal Neurons
Layer V Output"]
A --> I["Gamma Oscillations
40-100 Hz Frequency"]
I --> J["Theta Oscillations
4-8 Hz Frequency"]
J --> K["Thalamocortical Synchrony
Network Coordination"]
L["GluN2B Positive Modulator
Therapeutic Intervention"] --> A
L --> M["Enhanced NMDA Function
Prolonged Deactivation"]
M --> N["Sustained Depolarization
Temporal Integration"]
N --> K
O["Neurodegeneration
Pathological State"] --> P["Reduced GluN2B Expression
Receptor Downregulation"]
P --> Q["Disrupted Oscillations
Loss of Synchrony"]
Q --> R["Cognitive Impairment
Functional Outcome"]
classDef normal fill:#4fc3f7
classDef therapeutic fill:#81c784
classDef pathology fill:#ef5350
classDef outcome fill:#ffd54f
classDef molecular fill:#ce93d8
class A,B,C,D,E,M,N normal
class L therapeutic
class O,P,Q pathology
class R outcome
class F,G,H,I,J,K molecular